Ilan Sender

Ilan Sender is a Partner at Braidwell, a life science-focused investment firm based in New York, NY. In this role, he is responsible for providing flexible capital solutions and building strategic partnerships with innovative companies in the healthcare and biotechnology sectors, focusing on investments that accelerate advancements in human health. His work includes structuring financings across various asset classes—public, private, and structured—primarily targeted at companies transforming disease treatment, such as Caris Life Sciences.

Previously, Ilan held senior roles as Managing Director at The Blackstone Group’s Hedge Fund Solutions Group, where he focused on equity hedge fund strategies and alternative asset management, and at Claar Advisors, where he oversaw investment management responsibilities. His career highlights include leading and executing complex transactions in healthcare and managing strategic investments for major institutions, helping shape capital allocation toward life sciences innovation.

Ilan holds an MBA from Harvard Business School and a BSE in Computer Science from Princeton University. His expertise spans healthcare investing, structured finance, and alternative assets, and he is recognized for his contributions to financing pivotal biotech and healthcare companies, notably arranging significant financings that enable the growth and technological development of leaders in precision medicine.